SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

BLISS GVS PHARMA

BSE: 506197 31 Jul 2025
Healthcare
₹ 154.45
Bliss GVS Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

BLISS GVS PHARMA - Share Price & Details

Market Cap
₹1,931
High /Low
187.0 / 105.0
Stock P/E
18.1
Book Value
₹99.7
Dividend Yield
0.27
ROCE
11.7
ROE
₹8.36
Face Value
1.0
PEG Ratio
0.41
EVEBITDA
₹8.96
Debt
88.1
CMP / FCF
118.0
Debt to equity
₹0.08
NP Ann
90.3
High price all time
230.0
Piotroski score
₹4.0
Graham Number
151.0
No. Eq. Shares
10.6
Net CF
₹0.23
Net profit
112
Price to book value
1.84
Interest Coverage
₹14.2
Low price all time
0.95
Industry PE
33.3
Reserves
₹1,040
Free Cash Flow
₹33.0

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
BLISS GVS PHARMA LTD.1739.57210.531633.641.981,93118.1
AMRUTANJAN HEALTH CARE LTD.1402.33151.781354.145.25192094.2
JAGSONPAL PHARMACEUTICALS LTD.784.37107.95756.121.58187644.0

Peer Comparison Chart


About BLISS GVS PHARMA

Bliss GVS Pharma Limited, with Security Code 506197, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Bliss GVS Pharma Achieves 52-Week High Amid Broader Market Decline

(31 Jul 2025)
Bliss GVS Pharma's stock reached a new 52-week high of Rs. 190.65, reflecting strong performance amid a broader market decline.
Read more →

Pharma stock skyrockets 17% after company’s net profit increases by 167% QoQ

(30 Jul 2025)
Synopsis: Bliss GVS Pharma Ltd Q1 revenue rose 13% to Rs. 207 Crores YoY, and net profit grew 167% to Rs. 44.4 Crores QoQ. telegram channel...
Read more →

Bliss GVS Pharma soars 17% on 167% QoQ profit jump | Tap to know more | Inshorts

(30 Jul 2025)
the shares of bliss gvs pharma ltd soar 17 after the company announced its q1 results its revenue from operations rose by 5 percent qoq from...
Read more →

Bliss GVS Pharma Ltd Q1 FY2026 consolidated net profit surges to Rs. 43.03 crores

(30 Jul 2025)
The Board of Directors of Bliss GVS Pharma Limited, at its meeting held today have approved the financial results of the company for the...
Read more →

Bliss GVS Consolidated June 2025 Net Sales at Rs 207.47 crore, up 12.97% Y-o-Y

(30 Jul 2025)
Net Sales at Rs 207.47 crore in June 2025 up 12.97% from Rs. 183.64 crore in June 2024. Story continues below Advertisement.
Read more →

Bliss GVS Pharma Limited (BLISSGVS) Sees Unusual Trading Volume - Explosive returns

(26 Jul 2025)
Bliss GVS Pharma Limited (BLISSGVS) Sees Unusual Trading Volume ✌️【Market Insights】✌️ From micro-caps to blue-chips, we identify the top 1%...
Read more →

Company Updates